Real-World Issues in HIV Prevention & Treatment
The Critical Role of the Community Pharmacist
Meeting Slides
Clinical Practice Guidelines
ASHP Guidelines on Pharmacist Involvement in HIV Care.
Schafer JJ, et al. Am J Health Syst Pharm.2016;73(7):468-494.
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents.
US Department of Health and Human Services, 2017.
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV.
US Department of Health and Human Services, 2018.
Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations.
Centers for Disease Control and Prevention, 2018.
Screening Guidelines for Non–AIDS-defining Cancers in HIV-Infected Individuals.
Mani D, Aboulafia DM. Curr Opin Oncol. 2013;25(5):518-525.
STD and HIV Screening Recommendations.
Centers for Disease Control and Prevention, 2017.
Updated PrEP Clinical Practice Guideline and PrEP Clinical Providers’ Supplement—2017.
Centers for Disease Control and Prevention, 2017.
US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2014. A Clinical Practice Guideline.
Centers for Disease Control and Prevention, 2014.
Clinical Resources
American Academy of HIV Medicine | Supporting the HIV Care Provider and the Profession.
Brief Sexual History Tool.
Centers for Disease Control and Prevention.
Database of Antiretroviral Drug Interactions.
HIV Insite. University of California, San Francisco.
Fast-Track Cities.
International Association of Providers of AIDS Care (IAPAC), 2018.
HIV Drug Interactions.
University of Liverpool (Web site), 2018.
HIV in the United States by Geography.
Centers for Disease Control and Prevention, 2018.
PrEP Kit.
AIDS United, 2015.
Provider Information Sheet: PrEP During Conception, Pregnancy, and Breastfeeding.
Centers for Disease Control and Prevention.
State HIV Laws.
Centers for Disease Control and Prevention, 2018.
Taking a Sexual History.
NYC Health, 2015.
Transgender Health Learning Center.
University of California, San Francisco, 2018.
Patient Resources
HIV Risk Reduction Estimator.
Centers for Disease Control and Prevention, 2017
Centers for Disease Control and Prevention (CDC): HIV Basics.
The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum, including preexposure prophylaxis (PrEP).
Pill-Reminder Smartphone Apps (Free).
Mango Health – Medicine Manager, Pill Reminder for iPhone.
Medisafe Pill Reminder, Rx, & Medicine Tracker for iPhone.
Medisafe Meds & Pill Reminder for Android.
Positively Aware.
Positively Aware, created by TPAN (Test Positive Aware Network), is a source of HIV-treatment news for consumers, as well as an educational tool for HIV caregivers. The site features PrEP resources, including videos for men who have sex with men and transgender people.
PrEP for U.S. Women: A Collection of Resources.
HIVE (Website).
HIVE provides preconception and prenatal care and resources for women and couples affected by HIV.
Suggested Readings
Removing the stigma of HIV.
American Pharmacists Association, 2017.
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten JM, et al. N Engl J Med. 2012;367(5):399-410
Evaluating the impact of a pharmacist-led antiretroviral stewardship program on reducing drug interactions in HIV-infected patients.
Billedo JAS, et al. J Int Assoc Provid AIDS Care. 2016;15(1):84-88
Benefit of continuous/immediate ART on disease risk: SMART & START combined analysis.
Borges AH, et al. 24th Conference on Retroviruses and Opportunistic Infections; February 13−16, 2017; Seattle, WA. Abstract 474.
Pharmacists as providers of HIV pre-exposure prophylaxis.
Bruno C, Saberi P. Int J Clin Pharm. 2012;34(6):803-806.
Frequency of HIV testing and time from infection to diagnosis improve.
Centers for Disease Control and Prevention, 2017.
Innovative CDC effort expands HIV testing into pharmacies.
Centers for Disease Control and Prevention, 2012.
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.
Pharmacist-provided rapid HIV testing in two community pharmacies.
Darin KM, et al. J Am Pharm Assoc (2003). 2015;55(1):81-88.
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.
90-90-90: An ambitious treatment target to help end the AIDS epidemic.
Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014.
Assessment of the benefits of and barriers to HIV pharmacist credentialing.
McLaughlin M, et al. J Am Pharm Assoc (2003). 2018.
What is PrEP?
PrEP REP project.
Initiation of antiretroviral therapy in early asymptomatic HIV infection.
The INSIGHT START Study Group. N Engl J Med. 2015;373(9):795-807.
The Critical Role of the Community Pharmacist
Relevant Resources
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
What Do You Know About PrEP?
Got it? Treat it!
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
Key Issues Impacting OB/GYN Practice
Hot Topics in HBV, HCV, and NASH
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
Informing the Future of NASH Diagnosis and Assessment
A PEP/PrEP Training Guide for Pharmacists
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Establishing Clinical Readiness Through Mentored Learning
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
An Update on Best Practices
New Avenues to Pre-Exposure Prophylaxis
An Updated Clinician’s Guide to Assessment and Management
What the Pharmacist Needs to Know
A Look at the Changing HIV Playing Field
A “How To” Series Spanning Policy to Practice
Test Your Mastery!
Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention
Bringing HIV Prevention to a New Level
Optimizing HIV Prevention in Primary Care
Monoclonal Antibodies for the Prevention and Treatment of COVID-19
A Phone-a-Friend CME Series – Volume 2
Incorporating New Data and Updated Guidelines Into Daily Practice
Exercising Best Practices for Hospitalized Patients
